Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause

Menopause

Volumn 10, Issue 4, 2003, Pages 352-361

  Woo, Jean ^a,b   Lau, Edith ^a   Ho, Suzanne C ^a   Cheng, Francis ^a   Chan, Cynthia ^a   Chan, Agnes S Y ^a   Haines, Christopher J ^a   Chan, Thomas Y K ^a   Li, Martin ^a   Sham, Aprille ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cholesterol; Cognitive function; Hormone replacement therapy; Menopause; Pueraria lobata

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DEOXYPYRIDINOLINE; ESTRADIOL; FOLLITROPIN; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PHYTOESTROGEN; PLANT EXTRACT; PUERARIA LOBATA EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATTENTION; BONE TURNOVER; CANCER HORMONE THERAPY; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COGNITION; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HEALTH STATUS; HERBAL MEDICINE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MEMORY; MENOPAUSE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; OSTEOPOROSIS; PHYTOTHERAPY; POSTMENOPAUSE; QUALITY OF LIFE; QUESTIONNAIRE; RECALL; SCORING SYSTEM; SEX HORMONE DETERMINATION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; THINKING; TRADITIONAL MEDICINE; URINE LEVEL; VELOCITY;

EID: 0038164994     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000054764.94658.33     Document Type: Article

References (47)

1. Clinical Synthesis Panel on HRT. Hormone replacement therapy. Lancet 1999;354:152-155.
2. Barrett-Connor E. The menopause, hormone replacement and cardiovascular disease: the epidemiologic evidence. Maturitas 1996; 23:227-234.
3. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-613.
4. Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-333.
5. Yaffe K. Estrogens, selective estrogen receptor modulators, and dementia: what is the evidence? Ann N Y Acad Sci 2001;949:215-222.
6. Barrett-Connor E. Rethinking estrogen and the brain. J Am Geriatr Soc 1998;46:918-920.
7. Chan SG, Ho SC, Yip YB, Cheng YK. Health status and climacteric complaints in perimenopausal women in Hong Kong. Presented at: Meeting of the International Menopause Society; November 3-7, 1996; Sydney, Australia.
8. Haines CJ, Rong L, Chung TK, Leung DH. The perception of the menopause and the climacteric among women in Hong Kong. Prev Med 1995;24:245-248.
9. Fitzpatrick LA. Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women. Mayo Clin Proc 1999;74:601-607.
10. Murkies AL, Wilcox G, Davis SR. Clinical review 92: phytoestrogen. J Clin Endocrinol Metab 1998;83:297-303.
11. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996;87:897-904.
12. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998;91:6-11.
13. Kotsopoulos D, Dalais FS, Liang YL, McGrath BP, Teede HJ. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 2000;3:161-167.
14. Husband AJ. Phytoestrogens and menopause. BMJ 2002;324:52.
15. Setchell KDR, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999;129:758S-767S.
16. Sirtori CR. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Saf 2001;24:665-682.
17. White L, Petrovitch H, Ross G, et al. Brain aging and midlife tofu consumption. J Am Coll Nutr 2000;19:242-255.
18. Lien LL, Lien EJ. Hormone therapy and phytoestrogen. J Clin Pharm Ther 1996;21:101-111.
19. Chong Yao Da Tze Dian. Chiang Su New Medical College, Shanghai, China: Shanghai Science Technology Publisher, 1979:181-267.
20. Chang HM, But PPH. Pharmacology and Applications of Chinese Materia Medica, vol. 2. Singapore: World Scientific Publishing, 1987:1163-1166.
21. Ho SC, Chan SG, Yíp YB, Cheng A, Yi Q, Chan C. Menopausal symptoms and symptom clustering in Chinese women. Maturitas 1999;33:219-227.
22. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:2386-2391.
23. Kaplan EF, Goodglass H, Weintraub S, eds. The Boston Naming Test. Philadelphia, PA: Lea and Febiger, 1983.
24. Partington JE, Leiter RG. Partington's Pathway Test. Psychol Serv Cent Bull 1949;1:9-20.
25. Rectan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Interpretation. Tucson, AZ: Neuropsychology Press, 1985.
26. Chan AS, Kwok I. Hong Kong List-Learning Test. Manual and Preliminary Norm. Hong Kong: Department of Psychology and Clinical Psychology Center, The Chinese University of Hong Kong, 1999.
27. Lam CL, Gandek B, Ren XS, Chan MS. Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF36 health survey. J Clin Epidemiol 1998;51:1139-1147.
28. Reinli K, Block G. Phytoestrogen content of foods - a compendium of literature values. Nutr Cancer 1996;26:123-148.
29. Ho SC, Chan SG, Yi Q, Wong E, Leung PC. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 2001;16:1363-1369.
30. Franke AA, Custer LJ, Cerna CM, Narala K. Rapid HPLC analysis of dietary phytoestrogens from legumes and human urine. Proc Soc Exp Biol Med 1995;208:18-26.
31. Haines CJ, Chung TK, Masarei JR, Tomlinson B, Lau JT. The effect of percutaneous estrogen replacement therapy on Lp(a) and other lipoproteins. Maturitas 1995;22:219-225.
32. Miller PD, Baran DT, Bilezikian JP, et al. Practical clinical applications of biochemical markers of bone turnover. Consensus of an expert panel. J Clin Densitom 1999;2:323-342.
33. Jacobs DM, Tang MX, Stern Y, et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology 1998;50:368-73.
34. Davis SR. Phytoestrogen therapy for menopausal symptoms? BMJ 2001;323:354-355.
35. Chambers BA, Guo SS, Siervogel R, Hall G, Chumlea WC. Cumulative effects of cardiovascular disease risk factors on quality of life. J Nutr Health Aging 2002;6:179-184.
36. Arjmandi BH and Smith BJ. Soy isoflavones; osteoprotective role in postmenopausal women: mechanism of action. J Nutr Biochem 2002;13:130-137.
37. Chen K, Chan KJ. Preliminary basic science research into the treatment of dementia using Chinese herbal medicine [in Chinese]. J Tradit Chin Med West Med 1995;15:120-123.
38. Mathews K, Cauley J, Yaffe K, Zmuda JM. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 1999;47:518-523.
39. Smith YR, Giordani B, Lajiness-O'Neill R, Zubieta JK. Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women. Fertil Steril 2001;76:1101-1107.
40. Maki PM, Resnick SM. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage 2001;14:789-801.
41. Smith YR, Minoshima S, Kuhl DE, Zubieta JK. Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J Clin Endocrinol Metab 2001;86: 679-684.
42. Shaywitz SE, Shaywitz BA, Pugh KR, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999;281:1197-1202.
43. LeBlanc ES, Janoswky J, Chan BKS, Nelson HD. Hormone replacement therapy and cognition: systematic review and metaanalysis. JAMA 2001;285:1489-1499.
44. Steffens DC, Norton MC, Plassman BL, et al. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. J Am Geriatr Soc 1999;47:1171-1175.
45. Grodstein F, Chen J, Pollen DA, et al. Postmenopausal hormone therapy and cognitive function in healthy older women. J Am Geriatr Soc 2000;48:746-752.
46. Keenan PA, Ezzat WH, Ginsburg K, Moore GJ. Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology 2001;26:577-590.
47. Yaffe K, Krueger K, Sarkar S, et al. Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med 2001; 344:1207-1213.